Anti-hiv quinuclidine compounds

Details Anti-hiv quinuclidine compounds Anti-hiv quinuclidine compounds

A - Human Necessities

61

K

A61K 31/439 (2006.01) A61P 31/04 (2006.01) A61P 31/12 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2563109

The invention provides a therapeutic method for preventing or treating a pathological condition or symptom in a mammal, such as a human, wherein the infectivity of a pathogen such as a retrovirus toward mammalian cells is implicated and inhibition of its infectivity is desired comprising administering to a mammal in need of such therapy, an effective amount of a benzoylquinuclidine derivative that inhibits pathogenic infectivity, including pharmaceutically acceptable salts thereof.

L'invention concerne une méthode de prévention ou de traitement d'un état ou d'un symptôme pathologique chez un mammifère, notamment un être humain, dans lequel est impliquée l'infectivité d'un agent pathogène tel qu'un rétrovirus vis à vis des cellules. Pour inhiber cette infectivité, on administre à un mammifère qui en a besoin une dose efficace d'un dérivé de benzoquinuclidine ou de sels pharmaceutiquement acceptable de ce dérivé.

Affiliated with

Also associated with

Rating

Anti-hiv quinuclidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-hiv quinuclidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-hiv quinuclidine compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1877553